A comment on "Association between oral microbiome diversity and chronic obstructive pulmonary disease in the US population"
- PMID: 40528206
- PMCID: PMC12175404
- DOI: 10.1186/s12967-025-06715-9
A comment on "Association between oral microbiome diversity and chronic obstructive pulmonary disease in the US population"
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Conflict of interest: The authors declare that there are no conflicts of interest.
Similar articles
-
Association between oral microbiome diversity and chronic obstructive pulmonary disease in the US population.J Transl Med. 2025 May 17;23(1):557. doi: 10.1186/s12967-025-06553-9. J Transl Med. 2025. PMID: 40382665 Free PMC article.
-
[Prospective association between physical activity and mortality in patients with chronic obstructive pulmonary disease].Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Jun 18;57(3):537-544. doi: 10.19723/j.issn.1671-167X.2025.03.018. Beijing Da Xue Xue Bao Yi Xue Ban. 2025. PMID: 40509832 Free PMC article. Chinese.
-
Use of β-adrenoreceptor drugs and Parkinson's disease incidence in women from the French E3N cohort study.J Parkinsons Dis. 2025 Jun;15(4):789-804. doi: 10.1177/1877718X251330993. Epub 2025 Apr 29. J Parkinsons Dis. 2025. PMID: 40302366
-
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x. Respir Res. 2024. PMID: 39709425 Free PMC article. Review.
-
Gut microbiota and Parkinson's Disease: a new frontier in understanding neurological health.Inflammopharmacology. 2025 May;33(5):2565-2588. doi: 10.1007/s10787-025-01726-w. Epub 2025 Apr 17. Inflammopharmacology. 2025. PMID: 40244491 Review.
References
Publication types
LinkOut - more resources
Full Text Sources